In vitro studies of the cell-bound and antibody-mediated immunity evoked by murine renal allotransplants. Influence of presensitization, total body irradiation and immunosuppressive agents.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1553795)

Published in Clin Exp Immunol on June 01, 1973

Authors

B S Husberg

Articles cited by this

Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology (1968) 11.20

Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg (1969) 8.26

FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71

QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS. Transplantation (1965) 5.95

Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A (1971) 5.38

The role of macrophages in the induction of antibody in x-irradiated animals. Immunology (1967) 5.36

Effect of cortisone on survival of skin homografts in rabbits. Br Med J (1951) 4.98

Radiosensitive and radioresistant phases in the antibody response. J Immunol (1952) 4.76

Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis. J Exp Med (1965) 4.62

The histology of the tuberculin reaction and its modification by cortisone. Br J Exp Pathol (1951) 3.50

THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. II. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN ANTIGEN DOSE REQUIREMENT FOR SUSTAINED SYNTHESIS, ANAMNESIS, AND SENSITIVITY TO X-IRRADIATION. J Exp Med (1964) 3.42

ACTINOMYCIN INHIBITION OF RNA SYNTHESIS DIRECTED BY DNA. Fed Proc (1965) 3.14

Renal homotransplantation in man after radiation of the recipient. Experience with six patients since 1959. Am J Med (1962) 3.04

Immunological enhancement of rat kidney grafts. Lancet (1969) 2.73

APPLICATIONS OF ISO-IMMUNE CYTOLYSIS USING RADIOLABELLED TARGET CELLS. Nature (1964) 2.50

Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues. Fed Proc (1967) 2.44

Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc (1967) 2.44

Detection of agents which interfere with the immune response. Proc Soc Exp Biol Med (1962) 2.24

Enhancement of antibody formation by whole body x-radiation. J Exp Med (1963) 2.22

The effects of adrenocortical hormones, adrenocorticotrophic hormone and pregnancy on skin transplantation immunity in mice. J Endocrinol (1956) 2.01

QUANTITATIVE STUDIES ON THE BEHAVIOR OF SENSITIZED LYMPHOCYTES IN VITRO. II. INHIBITORY INFLUENCE OF THE IMMUNE SUPPRESSOR, IMURAN, ON THE DESTRUCTIVE REACTION OF SENSITIZED LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET CELLS. J Exp Med (1965) 1.98

The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76

Delayed hypersensitivity. V. The effect of x-irradiation on the development of delayed hypersensitivity and antibody formation. J Exp Med (1960) 1.52

A COMPARISON OF THE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ALLOGENEIC SKIN GRAFT SURVIVAL IN RATS. Bull Johns Hopkins Hosp (1965) 1.46

ENHANCED ANTITOXIN RESPONSES IN IRRADIATED MICE ELICITED BY COMPLEXES OF TETANUS TOXOID AND SPECIFIC ANTIBODY. J Immunol (1963) 1.39

A general method for the quantitation of immune cyotysis. Nature (1961) 1.39

Reduced antibody titers in mice treated with carcinogenic and cancer chemotherapeutic agents. Proc Soc Exp Biol Med (1952) 1.36

ACTINOMYCIN D: EFFECT ON THE IMMUNE RESPONSE. Science (1964) 1.26

Characteristic features of immunosuppression by steroids and cytotoxic drugs. Int Arch Allergy Appl Immunol (1968) 1.20

A COMPARISON OF THE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON THE PRIMARY AGGLUTININ RESPONSE IN RATS INJECTED WITH SHEEP ERYTHROCYTES. Bull Johns Hopkins Hosp (1964) 1.20

Studies on cells producing haemolytic antibodies against sheep red blood cells in short-term experiments in vitro. Immunology (1966) 1.17

Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med (1969) 1.14

THE EFFECT OF DELAYED ADMINISTRATION OF FOLINIC ACID ON IMMUNOLOGICAL INHIBITION BY METHOTREXATE. Immunology (1965) 1.13

Gamma-M and gamma-G antibodies in mice: dissociation of the normal immunoglobulin sequence. J Immunol (1966) 1.13

Effects of hydrocortisone succinate on the complement system. Nature (1965) 1.11

19S and 17S antibody production in the cyclophosphamide- or methotrexate-treated rat. Nature (1966) 1.11

The inhibition of hemagglutinin formation in mice by purine and pyrimidine analogues. J Immunol (1962) 1.08

Antilymphocytic antibody: effects in experimental animals and problems in human use. Ann Intern Med (1969) 1.08

Hormonal influence on lymphocyte differentiation from RES cells. Ann N Y Acad Sci (1960) 1.05

Inhibition of rapid production of antibody by cortisone; study of secondary response. Proc Soc Exp Biol Med (1952) 1.00

Kidney transplantation genetics and enhancement in rats. Transplant Proc (1971) 0.99

Symposium on immunosuppressive drugs. Variable influences of antitumor drugs and progestational agents on immune responses in rodents. Fed Proc (1967) 0.97

PROLONGATION OF HOMOGRAFT SURVIVAL BY METHOTREXATE WITH PROTECTION AGAINST TOXICITY BY FOLINIC ACID. Lancet (1964) 0.96

Effect of corticotropin on paralysis of experimental allergic encephalomyelitis. AMA Arch Neurol Psychiatry (1953) 0.96

The early effects of alloantibody and complement on rat kidney allografts. Transplantation (1972) 0.92

Renal transplantation in the inbred rat. XV. An assay study of three immunosuppressive drugs. Transplantation (1970) 0.90

The effects of some immunosuppressive agents on kidney graft survival in rats. Transplantation (1968) 0.90

The effects of aminopterin on guinea pig tuberculosis. Am J Pathol (1961) 0.89

PROBLEMS IN RENAL HOMOTRANSPLANTATION. JAMA (1964) 0.87

Cross-reacting TSTAs in adeno 7 and 12 tumors demonstrated by 51Cr-cytotoxicity and isograft rejection tests. Int J Cancer (1969) 0.83

The effect of adrenocorticotropic hormone on inflammation due to tuberculin hypersensitivity and turpentine and on circulating antibody levels. J Exp Med (1951) 0.82

Inhibition of the effect of cortisone on antibody formation by heterologous spleen cells. J Immunol (1961) 0.82

Regenerative potential of immunocompetent cells. 3. Recovery of primary antibody-forming potential from X-irradiation. The role of the thymus. J Immunol (1969) 0.82

Symposium on immunosuppressive drugs. Folate antagonists: some biochemical and pharmacological considerations. Fed Proc (1967) 0.80

6-Mercaptopurine and the homograft reaction. Surg Forum (1960) 0.80

THE TREATMENT OF CHRONIC MURINE HOMOLOGOUS DISEASE: A COMPARATIVE STUDY OF FOUR "IMMUNOSUPPRESSIVE" AGENTS. Transplantation (1965) 0.79

Quantitative serological determination of antibody formation in x-irradiated rabbits. J Immunol (1954) 0.79

A method for long term collection of lymph from the thoracic duct in rats. Acta Pathol Microbiol Scand (1960) 0.78

The effect of total body x-irradiation of the rabbit on the rejection of homologous skin grafts and on the immune response. J Immunol (1962) 0.78

[A technic for heterotopic kidney transplantation in rats]. Z Gesamte Exp Med (1968) 0.77

The effect of whole body x-irradiation on delayed hypersensitivity in the rat. Ann Med Exp Biol Fenn (1970) 0.76

Thoracic duct lymphocytes which have received 1000 rads in vitro do not recirculate. Br J Haematol (1969) 0.76

[Animal experiment's on the tolerance in skin allografts to antibiotics, cytostatic agents and enzyme inhibition]. Bruns Beitr Klin Chir (1968) 0.76

The effect of x-irradiation on delayed hypersensitivity and circulating antibody in the rat. J Immunol (1970) 0.76

Articles by these authors

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology (1993) 1.90

Impact of pretransplant renal function on survival after liver transplantation. Transplantation (1995) 1.58

Readmission to the intensive care unit after liver transplantation. Crit Care Med (2001) 1.54

De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg (1998) 1.42

The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41

Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery (1997) 1.41

Cryptococcosis after renal transplantation: report of ten cases. Surgery (1976) 1.41

The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation (1990) 1.37

Is liver transplantation indicated for cholangiocarcinoma? Am J Surg (1993) 1.20

Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients. Transplantation (1991) 1.18

A decade followup in early cases of renal homotransplantation. Ann Surg (1974) 1.16

Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx. Transplant Proc (1990) 1.14

Problematic vascular reconstruction in liver transplantation. Part I. Arterial. Surgery (1990) 1.12

Liver transplant in complete situs inversus: a case report. Surgery (1993) 1.12

Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation (1997) 1.10

Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome. Transplantation (1997) 1.09

The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet (1993) 1.08

Proceedings: The outcome of kidney retransplantation. Arch Surg (1974) 1.06

Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant (1998) 1.05

Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation (1996) 1.05

Problematic vascular reconstruction in liver transplantation. Part II. Portovenous conduits. Surgery (1990) 1.04

Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr (1996) 1.01

A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation (1990) 0.96

Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation (1998) 0.96

Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. Transplantation (1992) 0.95

Liver and kidney transplantation for polycystic disease. Transplantation (1998) 0.94

Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation (1996) 0.92

Coccidioidomycosis and renal transplantation. Transplantation (1977) 0.91

Simultaneous heart and kidney transplantation: a report of three cases and review of the literature. J Heart Lung Transplant (1992) 0.89

Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis (1992) 0.88

Rejection in liver transplantation. Hepatology (1989) 0.87

Does intraoperative hepatic artery flow predict arterial complications after liver transplantation? Transplantation (1998) 0.87

Quality of life improvements at one, two, and five years after liver transplantation. Transplantation (1995) 0.86

Simultaneous liver and renal transplantation in man. Transplantation (1988) 0.86

Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation (1997) 0.86

Baylor update: outcome analysis in liver transplantation. Clin Transpl (1993) 0.85

Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease. Transplant Proc (1992) 0.85

The safety of cardiac operations in the liver transplant recipient. Ann Thorac Surg (1998) 0.85

Five cases and five unusual indications for autogenic renal transplantation. Acta Chir Scand (1975) 0.83

Colon carcinoma in patients undergoing liver transplantation. Am J Surg (1998) 0.82

Results after liver retransplantation in a group of 50 regrafted patients: two different concepts of elective versus emergency retransplantation. Transpl Int (1991) 0.81

Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc (1992) 0.81

Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc (1991) 0.81

Recurrence of hepatitis B after liver transplantation: does hepatitis-B-immunoglobulin modify the recurrent disease? Transplant Proc (1990) 0.81

Late spontaneous rupture in a homografted kidney. A case report. Arch Surg (1974) 0.80

A randomized double-blind study of the effect of prophylactic immune globulin on the incidence and severity of CMV infection in the liver transplant recipient. Transplant Proc (1991) 0.80

FK506-associated thrombotic thrombocytopenic purpura. Transplantation (1993) 0.80

Retrospective evaluation of liver transplantation for cirrhosis: a comparative study of 100 patients with or without previous porto-systemic shunt. Transplant Proc (1991) 0.80

OKT3 rescue for steroid-resistant rejection in adult liver transplantation. Transplantation (1993) 0.79

Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation (1998) 0.79

A clear distinction between "immune activation of rejection" and "no immune activation" in liver transplant aspiration cytology. Transplant Proc (1988) 0.79

Meal patterns prior to and following liver transplantation in rats. Physiol Behav (1997) 0.79

Cytomegalovirus infection in orthotopic liver transplantation. Transpl Int (1989) 0.79

Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc (1995) 0.79

The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity. Clin Exp Immunol (1972) 0.78

Guidelines for surgical procedures after liver transplantation. Ann Surg (1998) 0.78

Superoxide dismutase improves organ preservation in liver transplantation. Transplant Proc (1988) 0.78

Liver transplantation: a review of the first 200 patients. Transplant Proc (1991) 0.78

A prospective randomized trial between Euro-Collins and University of Wisconsin solutions as the initial flush in hepatic allograft procurement. Transplantation (1992) 0.77

Lymphoproliferative disorder masquerading as rejection in liver transplant recipients--an early aggressive tumor with atypical presentation. Transplantation (1992) 0.77

Race and liver transplantation. Arch Surg (1991) 0.77

Perioperative renal function in patients undergoing orthotopic liver transplantation. A randomized trial of the effects of verapamil. Transplantation (1991) 0.77

Reader cites further programs in transplantation. Tex Med (1989) 0.75

Arterial grafts for revascularization of liver transplants. Transplant Proc (1989) 0.75

Enhanced growth of colon carcinoma isografts in rats concurrently receiving organ allografts. Transplant Proc (1981) 0.75

Cyclosporine nephrotoxicity in orthotopic liver transplantation. Transplant Proc (1988) 0.75

Liver transplant aspiration cytology is useful for monitoring steroid treatment of rejection. Transplant Proc (1988) 0.75

Cerebrospinal fluid inflammation during OKT3 therapy. Lancet (1987) 0.75

Rejection treatment with monoclonal OKT3 antibodies after renal transplantation--a case. Tex Med (1986) 0.75

Liver transplantation, 1990: a Dallas perspective. Clin Transpl (1990) 0.75

The impact of the different severe infections on the outcome of liver transplantation. A study of 150 patients. Transpl Int (1992) 0.75

Evaluation of transplanted kidneys with computed tomography and ultrasound. Scand J Urol Nephrol Suppl (1981) 0.75

Influence of cyclophosphamide on the antibody response evoked by an experimental sarcoma in rats. Transplantation (1978) 0.75

Hepatic transplantation in a patient with mesoatrial shunt and occlusion of the inferior vena cava. Surgery (1990) 0.75

Rejection: FK 506 for rescue or maintenance. Transplant Proc (1993) 0.75

The immunosuppressive effect of streptozotocin-induced diabetes in rats. Res Exp Med (Berl) (1986) 0.75

Influence of donor and recipient gender on the outcome of liver transplantation. Transplant Proc (1997) 0.75

Adenovirus infection of the human intestinal allograft: a case report. Transplant Proc (1996) 0.75

Liver transplant aspiration cytology (TAC) at three weeks and one year in healthy recipients with grafts free of histologic abnormality. Transplant Proc (1989) 0.75

Protection by cyclosporine A against normothermic liver ischemia-reperfusion in pigs. J Surg Res (1998) 0.75

Orthotopic liver transplantation and renal function; outcome of hepatorenal syndrome and trial of verapamil for renal protection in nonhepatorenal syndrome. Transplant Proc (1993) 0.75

The immunosuppressive effect of experimentally induced uremia. Nephron (1984) 0.75

Renal transplantation. Complications in patients with juvenile diabetes. Urology (1975) 0.75

Outcome analysis of FK 506 therapy for acute and chronic rejection. Transplant Proc (1993) 0.75